• Envue Medical held a special shareholder meeting on August 14, 2026.
• Shareholders authorized a potential reverse stock split, leaving the board discretion to set a 1-for-2 to 1-for-50 ratio.
• The reverse split was not executed at the meeting; any implementation must occur within one year of the meeting.
• Investors also adopted an adjournment resolution to allow more proxy solicitation if needed, though no adjournment was pursued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envue Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038305), on August 14, 2026, and is solely responsible for the information contained therein.